B-NON HODGKIN LYMPHOMA

Clinical trials for B-NON HODGKIN LYMPHOMA explained in plain language.

Never miss a new study

Get alerted when new B-NON HODGKIN LYMPHOMA trials appear

Sign up with your email to follow new studies for B-NON HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

Double-Punch CAR-T trial offers hope for kids with Tough-to-Treat leukemia

Disease control Recruiting now

This study is testing a new, experimental CAR-T cell therapy designed to fight two targets (CD19 and CD22) on cancer cells at once. It is for children and young adults (ages 3-39) whose B-cell leukemia or lymphoma has come back or hasn't responded to standard treatments. Doctors …

Matched conditions: B-NON HODGKIN LYMPHOMA

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 23, 2026 15:17 UTC

B-NON HODGKIN LYMPHOMA

Get alerted when new B-NON HODGKIN LYMPHOMA trials appear

Double-Punch CAR-T trial offers hope for kids with Tough-to-Treat leukemia